Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Impact of Brentuximab Vedotin in Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma with Capsule Infiltration Requiring Chemotherapy

Blood (2023) 142 (Supplement 1): 4439.

https://doi.org/10.1182/blood-2023-188896

Published: 2023

Journal Articles

Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey

Blood (2022) 140 (24): 2573–2583.

https://doi.org/10.1182/blood.2022015520

Published: 2022

Includes: Supplemental data

Journal Articles

Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma

Yuta Ito, Amira Marouf, Yasunori Kogure, Junji Koya, Mariko Tabata, Yuki Saito, Sumito Shingaki, Mitsuhiro Yuasa, Kentaro Yamaguchi, Julie Bruneau, Manon Vavasseur, Michaël Dussiot, Isabelle Andre, Akshay Joshi, Chantal Lagresle-Peyrou, Aude Magerus, Sammara Chaubard, David Lavergne, Emmanuel Bachy, Erika Brunet, Virginie Fataccioli, Chantal Brouzes, Camille Laurent, Laurence De Leval, Alexandra Traverse-Glehen, Céline Bossard, Marie Parrens, Véronique Meignin, Laure Philippe, Julien Rossignol, Felipe Suarez, Jean-Marie Michot, Olivier Tournilhac, Christine Bole-Feysot, Patrick Nitschke, Bruno Tesson, Cécile Laurent, Thierry Jo Molina, Vahid Asnafi, Sachiko Tsukita, Koji Izutsu, Hiroaki Miyoshi, Seiji Sakata, Akito Dobashi, Kengo Takeuchi, Koichi Ohshima, Philippe Gaulard, Arnaud Jaccard, Seishi Ogawa, Olivier Hermine, Keisuke Kataoka, Lucile Couronne

Blood (2022) 140 (Supplement 1): 1737–1739.

https://doi.org/10.1182/blood-2022-159869

Published: 2022

Journal Articles

Breast Implant Associated-Anaplastic Large-Cell Lymphoma (BIA-ALCL): Data Based on the Lymphoma Study Association (LYSA) Registry. Promising Results of Brentuximab Vedotin Combined with Cyclophosphamide, Doxorubicin and Prednisone (BV-CHP) As First Line Treatment for Patient Requiring Chemotherapy

Blood (2021) 138 (Supplement 1): 1387.

https://doi.org/10.1182/blood-2021-150478

Published: 2021

Journal Articles

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL

Blood (2020) 135 (5): 360–370.

https://doi.org/10.1182/blood.2019001904

Published: 2020

Includes: Supplemental data

Journal Articles

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Blood (2019) 134 (Supplement_1): 4021.

https://doi.org/10.1182/blood-2019-129123

Published: 2019

Journal Articles

Serum 2-Hydroxyglutarate in Angioimmunoblastic T Cell Lymphomas: A New Marker for IDH2 Mutation Detection and Monitoring

Sophie Broutin, PhD PharmD, Francois Lemonnier, MD PhD, Aurélie Dupuy, PhD, Julia Delahousse, Virginie Fataccioli, PhD, Vincent Ribrag, MD, Violaine Safar, MD, Laura Pelletier, Cyrielle Robe, Herve Tilly, MD, Anne Ségolène Cottereau, MD, Céline Bossard, MD, Laurence de Leval, MD, Marie-Helene Delfau, MD, Corinne Haioun, MD, Angelo Paci, PharmD, PhD, Philippe Gaulard, MD

Blood (2018) 132 (Supplement 1): 2898.

https://doi.org/10.1182/blood-2018-99-115893

Published: 2018

Journal Articles

Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma

François Lemonnier, Jehan Dupuis, Pierre Sujobert, Olivier Tournillhac, Morgane Cheminant, Clémentine Sarkozy, Laura Pelletier, Ambroise Marçais, Cyrielle Robe, Virginie Fataccioli, Corinne Haioun, Olivier Hermine, Philippe Gaulard, Richard Delarue

Blood (2018) 132 (21): 2305–2309.

https://doi.org/10.1182/blood-2018-04-840538

Published: 2018

Includes: Supplemental data

Journal Articles

Treatment with Hypomethylating Agent 5-Azacytidine Induces Sustained Response in Angioimmunoblastic T Cell Lymphomas

Richard Delarue, MD, Jehan Dupuis, MD, Pierre Sujobert, MD PhD, Sarah Barbieux, MD, Ambroise Marçais, MD, Olivier Tournilhac, MD PhD, Florence Lachenal, MD, Morgane Cheminant, MD, Clementine Sarkozy, MD, Virginie Fataccioli, PhD, Franck Morschhauser, Olivier Hermine, MD PhD, Corinne Haioun, MD PhD, Philippe Gaulard, MD PhD, Francois Lemonnier, MD PhD

Blood (2016) 128 (22): 4164.

https://doi.org/10.1182/blood.V128.22.4164.4164

Published: 2016

Journal Articles

Gene Expression Profiling Using a Reverse Transcriptase-Multiplex Ligation Dependant Probe Amplification Assay Allows for an Accurate Classification of Peripheral T-Cell Lymphoma and Highlights Novel Subgroups within the PTCL-NOS Category

Fanny Drieux, MD, Philippe Ruminy, PhD, Virginie Fataccioli, PhD, Vinciane Marchand, Marie Parrens, MD PhD, Céline Bossard, MD, Pierre Julien Viailly, Maria Pamela Dobay, PhD, Elena Liana Veresezan, MD, Anais Pujals, PhD, Aurélie Dupuy, PhD, Jean-Michel Picquenot, MD, Hervé Tilly, MD PhD, Laurence de Leval, MD PhD, Fabrice Jardin, MD PhD, Philippe Gaulard, MD PhD

Blood (2016) 128 (22): 2932.

https://doi.org/10.1182/blood.V128.22.2932.2932

Published: 2016

Journal Articles

Clinical Spectrum, Evolution and Management of Autoimmune Cytopenia Associated with Angioimmunoblastic T-Cell Lymphoma: A Retrospective, Multicenter Study

Etienne Crickx, MD, Radjiv Goulabchand, MD, Claire Fieschi, MD PhD, Lionel Galicier, MD, Paul Coppo, MD PhD, Veronique Meignin, MD, Richard Delarue, MD, Olivier Casasnovas, MD, Veronique Leblond, MD PhD, Guillaume Moulis, MD PhD, Marc Michel, MD PhD, Jehan Dupuis, MD, Fabien Le Bras, MD, Virginie Fataccioli, PhD, Corinne Haioun, MD PhD, Bertrand Godeau, MD PhD, Philippe Gaulard, MD PhD, Matthieu Mahevas, MD PhD

Blood (2016) 128 (22): 1816.

https://doi.org/10.1182/blood.V128.22.1816.1816

Published: 2016

Journal Articles

Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas

Blood (2016) 128 (11): 1490–1502.

https://doi.org/10.1182/blood-2016-02-698977

Published: 2016

Includes: Supplemental data

Journal Articles

Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma

Blood (2013) 122 (21): 842.

https://doi.org/10.1182/blood.V122.21.842.842

Published: 2013

Journal Articles

Small Nucleolar RNA Expression Profiling Identifies Potential Prognostic Markers in Peripheral T-Cell Lymphoma.

Loic Ysebaert, MD PhD, Wilfried Valleron, Laure Berquet, Virginie Fataccioli, PhD, Cathy Quelen, PhD, Antoine Martin, MD, Marie Parrens, MD, Laurence Lamant, MD, PhD, Laurence de Leval, MD PhD, Christian Gisselbrecht, Philippe Gaulard, MD, Pierre Brousset, MD, PhD

Blood (2012) 120 (21): 2678.

https://doi.org/10.1182/blood.V120.21.2678.2678

Published: 2012

Journal Articles

Angioimmunoblastic T-Cell Lymphoma (AITL) Is the Most Prevalent T-Cell Lymphoma Entity in Western Europe

Blood (2012) 120 (21): 1607.

https://doi.org/10.1182/blood.V120.21.1607.1607

Published: 2012

Journal Articles

Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma

Wilfried Valleron, Loic Ysebaert, Laure Berquet, Virginie Fataccioli, Cathy Quelen, Antoine Martin, Marie Parrens, Laurence Lamant, Laurence de Leval, Christian Gisselbrecht, Philippe Gaulard, Pierre Brousset

Blood (2012) 120 (19): 3997–4005.

https://doi.org/10.1182/blood-2012-06-438135

Published: 2012

Includes: Supplemental data

NARROW

Impact of Brentuximab Vedotin in Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma with Capsule Infiltration Requiring Chemotherapy

Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey

Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma

Breast Implant Associated-Anaplastic Large-Cell Lymphoma (BIA-ALCL): Data Based on the Lymphoma Study Association (LYSA) Registry. Promising Results of Brentuximab Vedotin Combined with Cyclophosphamide, Doxorubicin and Prednisone (BV-CHP) As First Line Treatment for Patient Requiring Chemotherapy

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Serum 2-Hydroxyglutarate in Angioimmunoblastic T Cell Lymphomas: A New Marker for IDH2 Mutation Detection and Monitoring

Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma

Treatment with Hypomethylating Agent 5-Azacytidine Induces Sustained Response in Angioimmunoblastic T Cell Lymphomas

Gene Expression Profiling Using a Reverse Transcriptase-Multiplex Ligation Dependant Probe Amplification Assay Allows for an Accurate Classification of Peripheral T-Cell Lymphoma and Highlights Novel Subgroups within the PTCL-NOS Category

Clinical Spectrum, Evolution and Management of Autoimmune Cytopenia Associated with Angioimmunoblastic T-Cell Lymphoma: A Retrospective, Multicenter Study

Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas

Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma

Small Nucleolar RNA Expression Profiling Identifies Potential Prognostic Markers in Peripheral T-Cell Lymphoma.

Angioimmunoblastic T-Cell Lymphoma (AITL) Is the Most Prevalent T-Cell Lymphoma Entity in Western Europe

Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only